title: Immunohistochemical evaluation of tissue-specific proteolytic enzymes in adenomas containing foci of early carcinoma: correlations with cathepsin D expression and other malignant features.
abstract: BACKGROUND
  Cathepsin D (CD) is an aspartyl lysosomal protease, and the prognostic value of CD expression has been studied in a variety of tumors, however, its role in early adenocarcinomas remains unclear.
  
  
  OBJECTIVE
  We evaluated the expression of CD in a series of colorectal adenomas with severe dysplasia containing foci of early carcinoma and compared the results to several histopathological and immunohistochemical features.
  
  
  METHODS
  Adenomas were obtained by endoscopic polypectomy from 33 patients. Twenty-four of the 33 adenomas contained well-differentiated adenocarcinomas and nine adenomas contained moderately differentiated adenocarcinomas.
  
  
  RESULTS
  Positive CD expressions were observed in 25% of well-differentiated adenocarcinomas and in 66.7% of moderately differentiated adenocarcinomas (p < 0.05). Of the 12 adenocarcinomas with positive CD expression, four had positive CD expression in their adenomas (p < 0.01), 6 showed positive Ki-67 expression in their adenomas (NS), and 10 had positive p53 expression in their adenomas (p < 0.05). No significant association was seen between the level of CD expression and adenoma size.
  
  
  CONCLUSIONS
  The expression of CD in adenocarcinoma correlated significantly with differentiation, and with the levels of CD and p53 expression in the adenomas of the polyp.
authors.affiliation: First Department of Pathology, Showa University School of Medicine, Tokyo, Japan. kunimura@med.showa-u.ac.jp
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Kunimura
authors.forename: Tomoko
authors.initials: T
authors.lastname: Inagaki
authors.forename: Masahiro
authors.initials: M
authors.lastname: Wada
authors.forename: Jun
authors.initials: J
authors.lastname: Ushio
authors.forename: Kasumi
authors.initials: K
authors.lastname: Sato
authors.forename: Tetsuji
authors.initials: T
authors.lastname: Enosawa
authors.forename: Masanao
authors.initials: M
authors.lastname: Nakashima
authors.forename: Hirotaka
authors.initials: H
authors.lastname: Kato
authors.forename: Ryouji
authors.initials: R
authors.lastname: Hayashi
authors.forename: Kouji
authors.initials: K
authors.lastname: Saitou
authors.forename: Toshio
authors.initials: T
authors.lastname: Morohoshi
mesh_terms: D000230:Adenocarcinoma / Q000201:enzymology* / Q000473:pathology; D000236:Adenoma / Q000201:enzymology* / Q000473:pathology; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002277:Carcinoma / Q000201:enzymology* / Q000473:pathology; D002402:Cathepsin D / Q000032:analysis / Q000096:biosynthesis*; D002454:Cell Differentiation; D015179:Colorectal Neoplasms / Q000201:enzymology* / Q000473:pathology; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D016159:Tumor Suppressor Protein p53 / Q000096:biosynthesis
chemical_list: D016159:Tumor Suppressor Protein p53; D002402:Cathepsin D